CN107753592A - It is a kind of to be used to treat burn, pharmaceutical composition of scald and preparation method thereof - Google Patents
It is a kind of to be used to treat burn, pharmaceutical composition of scald and preparation method thereof Download PDFInfo
- Publication number
- CN107753592A CN107753592A CN201711238090.8A CN201711238090A CN107753592A CN 107753592 A CN107753592 A CN 107753592A CN 201711238090 A CN201711238090 A CN 201711238090A CN 107753592 A CN107753592 A CN 107753592A
- Authority
- CN
- China
- Prior art keywords
- parts
- pharmaceutical composition
- borneol
- bubble
- wound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
It is used to treat burn, pharmaceutical composition of scald and preparation method thereof the invention provides a kind of, belongs to drug field.The pharmaceutical composition count in parts by weight including：Transplant seedlings 20~30 parts of bubble, 10~20 parts of 20~40 part, mao Xiucai of blue and green dish, 10~20 parts of borneol.Its preparation method includes：In parts by weight, the powdered bubble that transplants seedlings, blue and green dish, hair Xiucai are mixed with borneol.The pharmaceutical composition, it can rapidly relieve pain, stop blooding after use, molten scab, the cleaning surface of a wound, and there is good anti-infective effect, barrier can be formed on surface of a wound surface, avoiding the surface of a wound directly and air contact, so as to soften the surface of a wound, preventing bacterium implantation from breeding.Meanwhile the pharmaceutical composition can penetrate at incrustation, go directly skin surface, plays drug effect.
Description
Technical field
The present invention relates to drug field, in particular to it is a kind of be used to treating burn, the pharmaceutical composition of scald and its
Preparation method.
Background technology
In existing burn treating technology, the treatment to burn pain, more with intramuscular injection anodyne, oral analgesic etc.
Therapy.Shallow II degree burn.Shallow II degree burn wound is coated with flamazine or sulphadiazine silver-colored zinc frost, additional infrared ray toast,
Trauma surface infestation is controlled to dry wound exudate, scab is formed, promotes its subcrustal healing.In baking process, patient is cooperation
Baking, it is necessary to for a long time maintain same position, curative effect can be reached.Shallow II degree burn is treated above generally required for one to two week
Recovery from illness；Shallower deep ii degree burn, generally require three and fully recovered to surrounding, deeper deep II degree, III degree, IV degree fire victims are equal
Dermatoplastic treatment is needed to fully recover.
It is without skin not rawhide that doctor trained in Western medicine is theoretical, and skin-grafting needs general anesthesia, very great Cheng first from based on autologous skin, during skin-grafting
Degree adds medical-risk, the life security of serious threat to patient.Allograft skin, the skin of allograft skin are selected when autologous skin is inadequate
Source is less, and xenogenesis skin can be selected, but allograft skin and xenogenesis skin have more serious rejection phenomenon, and often high fever continues not patient
Move back, while skin-grafting also needs general anesthesia, massive transfusion is infused to maintain the balance of blood volume and Water-Electrolyte, prevents shock from sending out
It is raw.All therapeutic processes are both needed to largely next anti-infective using efficient antibiotic above, are typically all controlled in ad hoc bio-clean treatment unit
Treat, treatment condition is harsh, risk is big, cost is high, cycle length.
And the existing external-applied ointment for being used to treat burn, medicinal material species contained therein is more, and preparation technology is complicated,
It is with high costs.Obtained ointment is poor to the therapeutic effect of deeper deep II degree, III degree, IV degree fire victims, and it can not be effective
Resist trauma surface infestation so that the wound healing cycle is grown, and is also easy to leave stiff scar and color lump.
The content of the invention
The first object of the present invention is to provide a kind of pharmaceutical composition for being used to treat burn, scald, after use can
Enough rapid analgesics, hemostasis, molten scab, the cleaning surface of a wound, wound healing, the treatment of burn, scald available for large area, treatment
Effect is good.
The second object of the present invention is to provide a kind of preparation method of aforementioned pharmaceutical compositions, original used in this method
Expect cheap and easy to get, preparation method is simply easily implemented, and obtained pharmaceutical composition quality is high, good drug efficacy.
In order to realize the above-mentioned purpose of the present invention, spy uses following technical scheme：
It is a kind of be used for treat burn, scald pharmaceutical composition, the pharmaceutical composition count in parts by weight including：
Transplant seedlings 20~30 parts of bubble, 10~20 parts of 20~40 part, mao Xiucai of blue and green dish, 10~20 parts of borneol.
A kind of preparation method of aforementioned pharmaceutical compositions, it includes：
In parts by weight, the powdered bubble that transplants seedlings, blue and green dish, hair Xiucai are mixed with borneol.
Compared with prior art, beneficial effects of the present invention for example including：
This pharmaceutical composition provided by the invention, using being distributed in the bubble that transplants seedlings, blue and green dish, hair Xiucai these three natures
Extremely wide weeds plays dispersing swelling and dissipating binds, restrains the effect of relieving pain, removing necrosis and promoting granulation jointly as main pharmacodynamics composition；Simultaneously
It is aided with borneol again, fiery removing toxic substances can be dissipated, reduces the cusalgia sense of the surface of a wound.The pharmaceutical composition, can relieve pain rapidly after use,
Hemostasis, molten scab, the cleaning surface of a wound, and there is good anti-infective effect, barrier can be formed on surface of a wound surface, avoid the surface of a wound direct
With air contact, so as to soften the surface of a wound, the breeding of bacterium implantation is prevented.Meanwhile the pharmaceutical composition can penetrate at incrustation, directly
Up to skin surface, drug effect is played.Therefore, the pharmaceutical composition can be used for the treatment of the burn, scald of large area.Its preparation method
Used raw material is cheap and easy to get, and preparation method is simple, and obtained pharmaceutical composition quality is high, good drug efficacy.
Embodiment
Embodiment of the present invention is described in detail below in conjunction with embodiment, but those skilled in the art will
Understand, the following example is merely to illustrate the present invention, and is not construed as limiting the scope of the present invention.It is unreceipted specific in embodiment
Condition person, the condition suggested according to normal condition or manufacturer are carried out.Agents useful for same or the unreceipted production firm person of instrument, it is
The conventional products that can be obtained by commercially available purchase.
Present embodiment provides a kind of pharmaceutical composition for being used to treat burn, scald, and the pharmaceutical composition is by weight
Number meter includes：
Transplant seedlings 20~30 parts of bubble, 10~20 parts of 20~40 part, mao Xiucai of blue and green dish, 10~20 parts of borneol.
Or meter includes in parts by weight, 22~28 parts of the bubble that transplants seedlings, 12~18 parts of 23~37 part, mao Xiucai of blue and green dish, ice
12~18 parts of piece.
Or meter includes in parts by weight, 24~26 parts of the bubble that transplants seedlings, 13~16 parts of 30~36 part, mao Xiucai of blue and green dish, ice
14~17 parts of piece.
Or meter includes in parts by weight, transplant seedlings 25 parts of bubble, 15 parts of 32 part, mao Xiucai of blue and green dish, 15 parts of borneol.
In the pharmaceutical composition, the bubble that transplants seedlings (Rubus ellipticus var.obcordatus), it plants for the rose family
Thing transplants seedlings Fischer, is used as medicine with root and leaf, has the effect of swelling and pain relieving, astringing to arrest diarrhea；Blue and green dish (Cirsium setosum), its
For the herb or root of feverfew field thistle, there is the effect of clearing heat and relieving fidgetness, promoting the circulation of qi dissolving stasis, dispersing swelling and dissipating binds, suppression infection.Mao Xiu
, it is drying herb that feverfew shows arteries and veins Inula britannica chinensis (Duhaldea nervosa), has a dispelling wind and eliminating dampness, active pain relieving,
The effect of going rotten anti-inflammatory.These three medicinal material Synergistics, the effect of playing dispersing swelling and dissipating binds, convergence analgesic jointly, remove necrosis and promote granulation, energy
It is enough to promote burn, the wound healing of scald, and barrier can be formed on surface of a wound surface, avoid the surface of a wound directly and air contact, from
And soften the surface of a wound, prevent the breeding of bacterium implantation.
Meanwhile the pharmaceutical composition also includes borneol, its is pungent, bitter, is slightly cold, have lead to all keys, dissipate stagnated fire, swelling and pain relieving,
Heat-clearing dissipates poison, dissipate the effect of fire removing toxic substances.During treatment, when borneol effectively can alleviate pharmaceutical composition and be contacted with the surface of a wound
Caused burning heat sensation, pain is eliminated, mitigate the sense of discomfort of patient.Moreover it is possible to heat-clearing dissipates poison, prevents trauma surface infestation.
Further, the pharmaceutical composition also includes：The root of Dahurain angelica, count in parts by weight, the root of Dahurain angelica is 10~20 parts or is 13
~18 parts or for 14~16 parts or be 15 parts.The root of Dahurain angelica, it is its acrid flavour, warm-natured, there is relieving exterior syndrome and dispelling cold, the work(of wind-expelling pain-stopping
Effect.In the pharmaceutical composition, the root of Dahurain angelica can promote the dispersing swelling and dissipating binds of blue and green dish, suppress the effect of infection, contribute to shortening to control
Treat the cycle,
Further, the formulation of the pharmaceutical composition is exterior-applied formulation, and it can be：Powder, lotion, liniment, ointment,
Emplastrum, paste, patch, or can also be that other meet the actual formulation of needs.
Present embodiment also provides the preparation method of aforementioned pharmaceutical compositions, and it includes：
In parts by weight, the powdered bubble that transplants seedlings, blue and green dish, hair Xiucai are mixed with borneol, obtains mixed powder.
The mixed powder as made from the above method, powder, packed products can be made.During specifically used, it can incite somebody to action
The powder and permeation enhancers, which are mixed into, thick is coated on surface of a wound surface.Or directly the mixed powder can also be oozed with rush
Saturating agent mixing, is made externally used paste, convenient use and carrying.
The permeation enhancers can be vegetable oil, honey or glycerine.By being mixed with permeation enhancers, can effectively facilitate
Effect composition infiltrates into skin surface at surface of a wound incrustation and played a role, while and can forms layer protecting film on surface of a wound surface, keeps away
Exempt from the surface of a wound directly and air contact, so as to soften the surface of a wound, prevent the breeding of bacterium implantation.
Further, can be also mixed to get using solvent extraction method by above-mentioned by transplant seedlings bubble, blue and green dish, hair Xiucai and borneol
Mixed powder extracted, obtain herbal extract, after concentration, obtain extract；Again by the extract with pharmaceutically may be used
Auxiliary material or the carrier mixing of receiving.
Wherein, solvent extraction method includes：Decocting method, reflux extraction, ultrasonic oscillation extraction method, microwave loss mechanisms, leaching
Stain method and percolation.
Further, solvent extraction method is decocting method, and it includes：By mixed powder and water according to 1：7~10 solid-liquid ratio
Mixing, decoction 2 times, 1~2 hour every time, merging filtrate, the extract after concentration.
Further, solvent extraction method is reflux extraction, and it includes：By mixed powder and 70~85% ethanol solution
After mixing, heating and refluxing extraction 2 times, 1~2 hour every time, merging filtrate, the extract after concentration.
Further, solvent extraction method is ultrasonic oscillation extraction method, and it includes：Mixed powder is mixed with water, in work(
Rate is 700~800W, temperature is 0.5~1h of ultrasound at 40~60 DEG C, is circulated 2~3 times.
Further, solvent extraction method is microwave loss mechanisms, and it includes：Mixed powder is mixed with water, in microwave container
Interior extraction, 600~800W of power is extracted, centrifuged after extracting 0.5~1min.
Wherein, in the present embodiment, " pharmaceutically acceptable " refers to when the pharmaceutical composition is applied to human body, the medicine
Compositions are physiologically acceptable, comprising allergic reactions such as gastrointestinal disturbance, dizzinesses or anaphylactoid similar to these
Systemic anaphylaxis are not included.
In the present embodiment, " pharmaceutically acceptable auxiliary material " includes but is not limited to：Diluent (such as starch, cellulose
Deng), sorbefacient (such as fatty acid compound), wetting agent (such as glycerine) and surfactant (such as hexadecanol).
The pharmaceutical composition, it can rapidly relieve pain, stop blooding after use, molten scab, the cleaning surface of a wound, and with good anti-sense
Effect is contaminated, barrier can be formed on surface of a wound surface, avoid the surface of a wound directly and air contact, so as to soften the surface of a wound, prevent bacterium from
Bed breeding.Meanwhile the pharmaceutical composition can penetrate at incrustation, go directly skin surface, plays drug effect.Therefore, the medicine group
Compound can be used for the treatment of the burn, scald of large area, has the effect of fine for severe and following burn and scald, is adding medicine to
Cusalgia sense can be released in 1 hour afterwards, is significantly taken a turn for the better in 3 days, is thoroughly fully recovered within 2 weeks or so, not scar and color lump.Even
Medication after midway is infected, still effectively.In addition, the pharmaceutical composition can also be used for all kinds of bite by mosquitos and sore prevention and
Treatment.
The feature and performance of the present invention are described in further detail with reference to embodiments：
Embodiment 1
The present embodiment provides a kind of pharmaceutical composition for being used to treat burn, scald, and it includes：
Transplant seedlings bubble 25Kg, blue and green dish 30Kg, hair Xiucai 15Kg, borneol 15Kg.
The preparation method of the pharmaceutical composition includes：
The powdered bubble that transplants seedlings of above-mentioned formula ratio, blue and green dish, hair Xiucai and borneol are mixed, powder is made.
Embodiment 2
The present embodiment provides a kind of pharmaceutical composition for being used to treat burn, scald, and it includes：
Transplant seedlings bubble 20Kg, blue and green dish 40Kg, hair Xiucai 20Kg, borneol 10Kg.
The preparation method of the pharmaceutical composition includes：
The powdered bubble that transplants seedlings of above-mentioned formula ratio, blue and green dish, hair Xiucai and borneol are mixed, obtain mixed powder, then
The mixed powder is mixed with rapeseed oil, paste is made.
Embodiment 3
The present embodiment provides a kind of pharmaceutical composition for being used to treat burn, scald, and it includes：
Transplant seedlings bubble 30Kg, blue and green dish 20Kg, hair Xiucai 10Kg, borneol 20Kg.
The preparation method of the pharmaceutical composition includes：
The powdered bubble that transplants seedlings of above-mentioned formula ratio, blue and green dish, hair Xiucai and borneol are mixed, obtain mixed powder, then
The mixed powder is mixed with honey, paste is made.
Embodiment 4
The present embodiment provides a kind of pharmaceutical composition for being used to treat burn, scald, and it includes：
Transplant seedlings bubble 22Kg, blue and green dish 37Kg, hair Xiucai 12Kg, borneol 18Kg.
The preparation method of the pharmaceutical composition includes：
The powdered bubble that transplants seedlings of above-mentioned formula ratio, blue and green dish, hair Xiucai and borneol are mixed, obtain mixed powder, then
Extracted, i.e., mixed mixed powder with water using ultrasonic oscillation extraction method, surpassed in the case where power is 750W, temperature is 50 DEG C
Sound 40min, circulate 2 times, obtain extract solution, extract is obtained after concentration, then the extract is mixed with wetting agent, be made and put on the skin
Agent.
Embodiment 5
The present embodiment provides a kind of pharmaceutical composition for being used to treat burn, scald, and it includes：
Transplant seedlings bubble 28Kg, blue and green dish 23Kg, hair Xiucai 18Kg, borneol 12Kg.
The preparation method of the pharmaceutical composition includes：
The powdered bubble that transplants seedlings of above-mentioned formula ratio, blue and green dish, hair Xiucai and borneol are mixed, obtain mixed powder, then
Extracted using microwave loss mechanisms, i.e., mixed powder mixed with water, extracted in microwave container, extraction power be 700W,
Each extraction time be 1min, circulation 4 times, obtains extract solution, obtains extract after concentration, then by the extract and permeation enhancers
Mixing, liniment is made.
Embodiment 6
The present embodiment provides a kind of pharmaceutical composition for being used to treat burn, scald, and it includes：
Transplant seedlings bubble 28Kg, blue and green dish 23Kg, hair Xiucai 18Kg, borneol 12Kg, 10 parts of the root of Dahurain angelica.
The preparation method of the pharmaceutical composition is consistent with embodiment 1.
Embodiment 7
The present embodiment provides a kind of pharmaceutical composition for being used to treat burn, scald, and it includes：
Transplant seedlings bubble 25Kg, blue and green dish 20Kg, hair Xiucai 15Kg, borneol 15Kg, 20 parts of the root of Dahurain angelica.
The preparation method of the pharmaceutical composition is consistent with embodiment 1.
Embodiment 8
The present embodiment provides a kind of pharmaceutical composition for being used to treat burn, scald, and it includes：
Transplant seedlings bubble 24Kg, blue and green dish 30Kg, hair Xiucai 16Kg, borneol 14Kg, 15 parts of the root of Dahurain angelica.
The preparation method of the pharmaceutical composition is consistent with embodiment 1.
Experimental example
The pharmaceutical composition that the embodiment of the present invention 1~8 provides is controlled II degree fire victims with reference to clinical test
Therapeutic effect is evaluated：
First, testing program：
1. case selection：
This group of case is II degree fire victims, meet include, exclusion standard, age 14-49 year, average 29 years old.At random
It is divided into 9 groups, every group each 30, wherein experimental group is the 1st~8 group, and control group is the 9th group.The age of this 9 groups of patients, burn surface
There was no significant difference for the data such as product, the state of an illness, has comparativity.
2. therapeutic scheme：
After each group patient is admitted to hospital, burn wound and surrounding skin are cleaned using 5% iodophor disinfection.Difference is,
1st~8 group of (experimental group) patient applies the pharmaceutical composition that embodiment 1-8 is provided respectively, is applied at the surface of a wound, and without extra
Blister skin is punctured, daily to smear 1 time, the amount smeared every time is advisable with flap coverage.9th group of (control group) patient is treated using tradition
Method is treated, i.e., is coated with outside burn wound with flamazine, additional infrared ray baking.
The situation of change of observation wounds in one week treatment：Redness, ooze out regression time, surface of a wound scab forming time, the surface of a wound
Healing time and whether there is other infection conditions.
3. clinical evaluation standard：
The surface of a wound is red and swollen, disappears：Visually observe, the surface of a wound without it is obvious it is red and swollen, ooze out stopping；
Surface of a wound scab forming time：Visually observe, it is timing node that the surface of a wound, which initially forms dry crust,；
Wound healing time：Visually observe, the complete epithelialization of the surface of a wound, it is timing node to form pink and dry the surface of a wound.
4. statistical procedures：
All data carry out statistical procedures using SPSS17.0 softwares.All data use mean ± standard deviation (x ± s)
Represent, examined between 11 groups using t, be that difference has statistical significance with P ＜ 0.05.
2nd, result of the test：
As shown in table 1：
The clinical test results of table 1.
| Project | Red and swollen regression time (d) | Surface of a wound scab forming time (d) | Wound healing time (d) |
| Embodiment 1 | 1.8±0.4 | 5.4±0.3 | 9.2±0.2 |
| Embodiment 2 | 1.9±0.1 | 5.5±0.4 | 9.4±0.3 |
| Embodiment 3 | 1.8±0.7 | 5.4±0.2 | 9.6±0.1 |
| Embodiment 4 | 2.0±0.5 | 5.7±0.7 | 9.4±0.8 |
| Embodiment 5 | 2.1±0.6 | 5.6±0.5 | 9.3±0.5 |
| Embodiment 6 | 1.7±0.4 | 5.2±0.3 | 8.8±0.3 |
| Embodiment 7 | 1.8±0.2 | 5.3±0.4 | 8.7±0.7 |
| Embodiment 8 | 1.7±0.6 | 5.1±0.6 | 9.0±0.1 |
| Control group | 4.8±0.2 | 8.7±0.1 | 12.8±0.4 |
As shown in Table 1：
The pharmaceutical composition provided in the present invention is excellent to the therapeutic effect of burn wound, is mainly manifested in：It is in medication
After agent, red and swollen regression can be enable in 2 days, the surface of a wound is formed a scab and the surface of a wound is reached in 10 days in 5~6 days
Basic healing.In addition, after pharmaceutical composition in embodiment 1-8 is applied, no allergy, toxic reaction, also without superinfection symptom,
And after using medicament two weeks, wound repair is complete, is visible by naked eyes scar.
Although illustrate and describing the present invention with specific embodiment, but will be appreciated that without departing substantially from the present invention's
Many other change and modification can be made in the case of spirit and scope.It is, therefore, intended that in the following claims
Including belonging to all such changes and modifications in the scope of the invention.
Claims (10)
1. a kind of be used to treat burn, the pharmaceutical composition of scald, it is characterised in that described pharmaceutical composition is counted in parts by weight
Including：
Transplant seedlings 20~30 parts of bubble, 10~20 parts of 20~40 part, mao Xiucai of blue and green dish, 10~20 parts of borneol.
2. pharmaceutical composition according to claim 1, it is characterised in that count in parts by weight, the bubble that transplants seedlings for 22~
28 parts, the blue and green dish be 23~37 parts, the hair Xiucai is 12~18 parts, the borneol is 12~18 parts.
3. pharmaceutical composition according to claim 1, it is characterised in that count, count in parts by weight in parts by weight, it is described
The bubble that transplants seedlings is 24~26 parts, the blue and green dish is 30~36 parts, the hair Xiucai is 13~16 parts, the borneol is 14~17
Part.
4. pharmaceutical composition according to claim 1, it is characterised in that described pharmaceutical composition also includes the root of Dahurain angelica, described
The root of Dahurain angelica is calculated by weight as 10~20 parts.
5. pharmaceutical composition according to claim 1, it is characterised in that described pharmaceutical composition also includes the root of Dahurain angelica, described
The root of Dahurain angelica is calculated by weight as 13~18 parts.
6. pharmaceutical composition according to claim 1, it is characterised in that the formulation of described pharmaceutical composition includes：Powder,
Lotion, liniment, ointment, emplastrum, paste, patch.
7. the preparation method of a kind of pharmaceutical composition as described in any one of claim 1~6, it is characterised in that it includes：
In parts by weight, transplanted seedlings described in will be powdered bubble, the blue and green dish, the hair Xiucai mixes with the borneol.
8. the preparation method of pharmaceutical composition according to claim 7, it is characterised in that by the bubble that transplants seedlings, the green grass or young crops
After green vegetables, the hair Xiucai and the borneol are mixed to get mixed powder, in addition to the mixed powder mixed with permeation enhancers
Close；The permeation enhancers include at least one of vegetable oil, honey and glycerine.
9. the preparation method of pharmaceutical composition according to claim 7, it is characterised in that by the bubble that transplants seedlings, the green grass or young crops
After green vegetables, the hair Xiucai and the borneol are mixed to get mixed powder, in addition to the mixed powder used into solvent extraction
After method is extracted, then mixed extract obtained with pharmaceutically acceptable auxiliary material or carrier.
10. the preparation method of pharmaceutical composition according to claim 9, it is characterised in that the auxiliary material or carrier include：
At least one of diluent, sorbefacient, wetting agent and surfactant.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711238090.8A CN107753592A (en) | 2017-11-30 | 2017-11-30 | It is a kind of to be used to treat burn, pharmaceutical composition of scald and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711238090.8A CN107753592A (en) | 2017-11-30 | 2017-11-30 | It is a kind of to be used to treat burn, pharmaceutical composition of scald and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107753592A true CN107753592A (en) | 2018-03-06 |
Family
ID=61276659
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711238090.8A Pending CN107753592A (en) | 2017-11-30 | 2017-11-30 | It is a kind of to be used to treat burn, pharmaceutical composition of scald and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107753592A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110038115A (en) * | 2019-04-18 | 2019-07-23 | 北京和生康医疗科技有限公司 | Mineral substance type alkaline compositions and preparation method thereof and purposes |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7235265B2 (en) * | 2005-10-31 | 2007-06-26 | Ross Rosen | Herbal skin formulation |
| CN102068614A (en) * | 2009-11-19 | 2011-05-25 | 史海霞 | Traditional Chinese medicine for treatment of burn and scald |
-
2017
- 2017-11-30 CN CN201711238090.8A patent/CN107753592A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7235265B2 (en) * | 2005-10-31 | 2007-06-26 | Ross Rosen | Herbal skin formulation |
| CN102068614A (en) * | 2009-11-19 | 2011-05-25 | 史海霞 | Traditional Chinese medicine for treatment of burn and scald |
Non-Patent Citations (1)
| Title |
|---|
| 陈玉璞，: "大黄冰片治疗烧伤62例", 《中国民间疗法》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110038115A (en) * | 2019-04-18 | 2019-07-23 | 北京和生康医疗科技有限公司 | Mineral substance type alkaline compositions and preparation method thereof and purposes |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3466447B1 (en) | Pharmaceutical composition for treating multiple forms of skin wounds and manufacturing method thereof | |
| CN104922248A (en) | Antibacterial and anti-inflammatory Chinese herbal compound gel and preparation method thereof | |
| CN103055052A (en) | Cream for treating burn and scald and preparation method of cream | |
| CN102266406B (en) | Chinese medicinal ointment for treating burn and preparation method | |
| CN104096047A (en) | Externally-applied detoxification ointment for treatment of poisonous snake bite wound and preparation method thereof | |
| CN101612290B (en) | Medicinal composition for treating burn and scald and preparation method thereof | |
| CN1679888A (en) | Decoction Chinese medicine sterilizing antiphlogistic, preparation and use thereof | |
| CN107753592A (en) | It is a kind of to be used to treat burn, pharmaceutical composition of scald and preparation method thereof | |
| CN101797303A (en) | Chinese medicinal plaster for treating burns and scalds | |
| CN106377602A (en) | Dendrobium officinale composite disinfection powder, and preparation method and application method thereof | |
| CN105560620A (en) | Trauma treatment traditional Chinese medicine preparation | |
| KR100494348B1 (en) | Drug for treatment of a burn and preparing process thereof | |
| CN102106920A (en) | Chinese medicinal composition for treating burn and scald and application thereof | |
| CN101297866B (en) | Chinese medicament oil solution for treating burn and preparation thereof | |
| CN108079050A (en) | Herbal skin bacteria inhibiting composition and preparation method and application | |
| CN103263496B (en) | Medicinal composition for treating burn | |
| CN103446240A (en) | Traditional Chinese medicine composition for rapidly healing wounds | |
| CN101371880B (en) | Chinese medicinal composition for treating empyrosis wound surface | |
| CN103083503B (en) | Skin and external disease plaster and preparation method thereof | |
| CN109498735A (en) | Medicine for treating mosquito bites and preparation method thereof | |
| CN103893422B (en) | Repair medicine of skin injury and preparation method thereof | |
| CN108066518A (en) | A kind of dog Chinese medicine bath lotion composition and preparation method thereof | |
| Goswami et al. | A critical review on traditional herbal plant ‘tulsi’ | |
| CN107050298A (en) | A kind of Chinese medicine paste formulation and preparation method for treating burn and scald skin damaged | |
| CN104940389B (en) | Treat Chinese medicine preparation of Shelled Turtle Trionyx Sinensis blister sore and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180306 |